![Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/81d8806a-ceca-4797-a348-730575326f2a/gr1_lrg.jpg)
Adjustable intragastric balloon for treatment of obesity: a multicentre, open-label, randomised clinical trial - The Lancet
![Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3bf08982-433a-4e78-933c-d49e6ac25024/gr1_lrg.jpg)
Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial - The Lancet
![Abstract 16784: Under-Enrollment of Real-World Heart Failure With Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials | Circulation Abstract 16784: Under-Enrollment of Real-World Heart Failure With Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials | Circulation](https://www.ahajournals.org/cms/asset/1c5e4007-1632-4d74-9907-2ee083cb9148/g16784.jpg)
Abstract 16784: Under-Enrollment of Real-World Heart Failure With Preserved Ejection Fraction Patients in Major HFpEF Clinical Trials | Circulation
![Clinical review of subcutaneous semaglutide for obesity - Phillips - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library Clinical review of subcutaneous semaglutide for obesity - Phillips - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/57acdfa7-6ba9-416a-9574-5966c6408631/jcpt13574-toc-0001-m.jpg)
Clinical review of subcutaneous semaglutide for obesity - Phillips - 2022 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
![Searching for answers: Why I'm studying obesity through clinical research | Heart | UT Southwestern Medical Center Searching for answers: Why I'm studying obesity through clinical research | Heart | UT Southwestern Medical Center](https://s3-us-west-2.amazonaws.com/utsw-patientcare-web-production/original_images/blog_feb_2017_neeland-obesity-research.jpg)
Searching for answers: Why I'm studying obesity through clinical research | Heart | UT Southwestern Medical Center
![Development of a clinical trials version of the Impact of Weight on Quality of Life‐Lite questionnaire (IWQOL‐Lite Clinical Trials Version): results from two qualitative studies - Kolotkin - 2017 - Clinical Obesity - Development of a clinical trials version of the Impact of Weight on Quality of Life‐Lite questionnaire (IWQOL‐Lite Clinical Trials Version): results from two qualitative studies - Kolotkin - 2017 - Clinical Obesity -](https://onlinelibrary.wiley.com/cms/asset/22d1e7d3-136a-476a-a69e-a6a506487137/cob.2017.7.issue-5.cover.jpg)
Development of a clinical trials version of the Impact of Weight on Quality of Life‐Lite questionnaire (IWQOL‐Lite Clinical Trials Version): results from two qualitative studies - Kolotkin - 2017 - Clinical Obesity -
![This study is recruiting male participants looking to lose weight.To see if you are eligible, please click the button below. | Clinical Research Trial Listing ( Obesity | Weight loss | Overnutrition This study is recruiting male participants looking to lose weight.To see if you are eligible, please click the button below. | Clinical Research Trial Listing ( Obesity | Weight loss | Overnutrition](https://www.centerwatch.com/media/img/253_Website_Header_06_2021_U1Bk4DN.jpg)